Skip to content
Biodatica
Start free

Investigator

Wei Guo

WISTAR INSTITUTE · funded by NCI, NIGMS

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.7M

Summed across those awards.

First award
May 1, 2021

Latest Sep 3, 2021.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P50

    Targeting exosomal PDL1 to improve immunotherapy

    $445k

    Sep 3, 2021NCIWISTAR INSTITUTENIH RePORTER · 11187259 (opens the source filing in a new tab)

  2. R35

    Molecular Basis and Regulatory Mechanisms of Exosome Secretion

    $621k

    May 1, 2021NIGMSUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11076293 (opens the source filing in a new tab)

  3. R35

    Molecular Basis and Regulatory Mechanisms of Exosome Secretion

    $640k

    May 1, 2021NIGMSUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11259763 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources